STOPP/START criteria and prevention of hospital admissions

A Dutch research-group studied the association between inappropriate prescribing and hospital admissions as a nested case-control study of the HARM study. They concluded that patients with potentially inappropriate prescribing, detected with the STOPP & START 2008 criteria, are at risk of preventable medication-related hospital admissions. The STOPP & START 2008 criteria can be used to identify older people at risk of medication-related problems. The study is published in Drug Safety January 2016, Volume 39, Issue 1, pp 79-87.

Second OPERAM meeting in Utrecht

The second OPERAM meeting will take place at 11 and 12 January 2016 in Bunnik close to Utrecht. During this meeting the set up of the OPERAM trial and especially the use of the new version of the STRIPassistant, the implementation of the medication review and adjudication of adverse effects will be discussed. Also the health economics part of the trial and the performance of the systematic reviews and network meta-analysis are topics at this meeting.

Thesis of Michiel Meulendijk ‘Optimizing medication reviews through decision support: prescribing a better pill to swallow’

The thesis of Michiel Meulendijk ‘Optimizing medication reviews through decision support: prescribing a better pill to swallow’ is as pdf available on this website (see research). In this thesis the development of the STRIPassistant is described. The STRIP is a structured method to reduce inappropriate prescribing and is developed by Ephor in cooperation with general practitioners.

Health Relevance of Shingles Vaccination in the Elderly Population

Europe-ExPro is an institute that identifies clinical, economic and patient related issues in certain disease areas that require an assessment by experts. Europe-ExPro brings forth expert procedures on these issues. The expert procedure aims to define the relevance between the new treatment option and the existing treatment options. This is done from different perspectives, such as clinical, economic or patient perspective. By evidence based and practice based methods the relevant differences are validated. The expert procedure results in a report for public use and a manuscript available for submission in an appropriate journal. The link to the website is here provided (see Link).

Deprescribing definition

There is lack of consensus on the definition of deprescribing. A review of Reeve et al., accepted for publication in the British Journal of Clinical Pharmacology (Aug 2015), proposes the following definition: „Deprescribing is the process of withdrawal of an inappropriate medication, supervised by a health care professional with the goal of managing polypharmacy and improving outcomes‟. This definition has not yet been externally validated and further work is required to develop an internationally accepted and appropriate definition.